Therefore, although the true effect might be different from 0, the observed effect sizes and confidence intervals suggest that any impact of IL‐6 signaling downregulation on cSVD outcomes would be smaller than the effects observed for atherosclerosis‐related end points. Here, IL6 is linked to atherosclerosis.